MedPath

DIFLUNISAL

DIFLUNISAL

Dormant
DIN Number

02039486

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

aa pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02039486
AIG Number0113161001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BA11 DIFLUNISAL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

DIFLUNISALActive
Strength: 250 MG
Monograph: DIFLUNISAL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.